Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

SCIMITAR is the first phase 2 trial testing the efficacy of stereotactic body radiation therapy (SBRT) targeting the prostate fossa after radical prostatectomy.

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

Investigators proposed novel PSA thresholds for prostate cancer biochemical recurrence: PSA nadir plus 0.5 ng/mL after radiation therapy and PSA 0.5 ng/mL or higher with a PSA doubling time of 9 ...

Post-RP prognosis was distinguishable at a nadir PSA level of ≤0.03 ng/mL vs higher. A PSA level of 0.04 ng/mL or higher may optimally define PSA persistence in patients who have had radical ...

The actor said his family history motivated him to do PSA testing (prostate-specific antigen) ever year since he was 41.

"Grey's Anatomy" star James Pickens Jr. revealed his prostate cancer diagnosis, sharing a public service announcement on the ...